Managing recalcitrant hypercholesterolemia in patients on current best standard of care: efficacy and safety of novel pharmacotherapies-Reference-Cited by-同舟云学术

Managing recalcitrant hypercholesterolemia in patients on current best standard of care: efficacy and safety of novel pharmacotherapies

Published:2014-04-01 Issue:2 Volume:9 Page:221-233
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Sahebkar Amirhossein¹²,Watts Gerald F³

Affiliation:

1. Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2. Cardiovascular Research Center, Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

3. Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital & Metabolic Research Centre, School of Medicine & Pharmacology, University of Western Australia, Perth, Australia

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.14.14

Reference75 articles.

1. Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 112(22), 3375–3383 (2005).

2. Watts GF, Gidding S, Wierzbicki AS et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int. J. Cardiol. 171(3), 309–325 (2014). •• A comprehensive review describing the latest guidelines for the identification and management of familial hypercholesterolemia (FH).

3. Nordestgaard BG, Chapman MJ, Humphries SE et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. Eur. Heart J. 34(45), 3478–3490 (2013). •• A comprehensive review describing the latest guidelines for the identification and management of FH.

4. WHO. Familial hypercholesterolaemia: report of a WHO consultation. WHO, Paris, France (1997).

5. Fahed AC, Nemer GM. Familial hypercholesterolemia: the lipids or the genes? Nutr. Metab. (Lond.) 8(1), 23 (2011).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta‐analysis of the impact of cornelian cherry consumption on blood lipid profiles;Food Science & Nutrition;2021-06-21

2. Effects of vitamin D supplementation on serum lipid profile in women with polycystic ovary syndrome;Medicine;2020-06-05

3. Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials;Pharmacological Research;2016-09

4. Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials;Pharmacological Research;2016-04

5. Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials;British Journal of Clinical Pharmacology;2016-02-02